Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury
暂无分享,去创建一个
R. Bellomo | J. Kellum | C. Doig | V. Pettilä | A. Zarbock | R. Mehta | R. Ferrer | P. Pickkers | P. Laterre | M. Bestle | P. Young | K. Doi | M. Joannidis | P. Murray | M. Ostermann | A. Kjølbye | De Angus | J. Arend | B. François | Juliane Bernholz | Kathleen D. Liu | E. van den Berg | Kristine Broglio | Jan Carlsen | Sharon Richards | Kent Doi